AQR Capital Management
BEAT

AQR Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

AQR Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,480
Closed -$250K – 2322
2020
Q3 		$250K Buy
+5,480
New +$229K ﹤0.01% 1986
2019
Q4 		– Sell
-23,896
Closed -$973K – 2246
2019
Q3 		$973K Sell
23,896
-23,346
-49% -$1.01M ﹤0.01% 1531
2019
Q2 		$2.27M Sell
47,242
-2,023
-4% -$106K ﹤0.01% 1218
2019
Q1 		$3.08M Buy
49,265
+13,238
+37% +$909K ﹤0.01% 1165
2018
Q4 		$2.15M Buy
36,027
+26,892
+294% +$1.61M ﹤0.01% 1219
2018
Q3 		$589K Buy
9,135
+3,066
+51% +$171K ﹤0.01% 1898
2018
Q2 		$273K Sell
6,069
-8,692
-59% -$347K ﹤0.01% 2148
2018
Q1 		$458K Sell
14,761
-6,742
-31% -$222K ﹤0.01% 1934
2017
Q4 		$643K Sell
21,503
-8,254
-28% -$239K ﹤0.01% 1832
2017
Q3 		$982K Sell
29,757
-51,869
-64% -$1.8M ﹤0.01% 1681
2017
Q2 		$2.73M Sell
81,626
-29,874
-27% -$891K ﹤0.01% 1262
2017
Q1 		$3.23M Sell
111,500
-59,406
-35% -$1.47M ﹤0.01% 1184
2016
Q4 		$3.82M Sell
170,906
-53,590
-24% -$1.05M 0.01% 1142
2016
Q3 		$4.17M Buy
224,496
+75,552
+51% +$1.42M 0.01% 1076
2016
Q2 		$2.43M Buy
148,944
+45,609
+44% +$671K ﹤0.01% 1213
2016
Q1 		$1.21M Sell
103,335
-31,327
-23% -$350K ﹤0.01% 1506
2015
Q4 		$1.57M Buy
134,662
+81,062
+151% +$1.03M ﹤0.01% 1368
2015
Q3 		$656K Buy
53,600
+19,453
+57% +$248K ﹤0.01% 1621
2015
Q2 		$322K Buy
34,147
+17,176
+101% +$159K ﹤0.01% 1956
2015
Q1 		$150K Hold
16,971
– – ﹤0.01% 2048
2014
Q4 		$170K Sell
16,971
-26,700
-61% -$229K ﹤0.01% 2393
2014
Q3 		$293K Sell
43,671
-24,000
-35% -$168K ﹤0.01% 2197
2014
Q2 		$485K Buy
67,671
+200
+0.3% +$1.59K ﹤0.01% 1995
2014
Q1 		$681K Buy
67,471
+1,100
+2% +$10.1K ﹤0.01% 1888
2013
Q4 		$527K Hold
66,371
– – ﹤0.01% 2038
2013
Q3 		$658K Buy
+66,371
New +$522K ﹤0.01% 1861

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

AQR Capital Management's BEAT Position: Q4 2020 in Review

AQR Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 5,480 shares — an estimated $250K sold.

AQR Capital Management first reported a position in BEAT in Q3 2013 and held it in 26 quarters. The position peaked at $4.17M in Q3 2016. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • AQR Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • AQR Capital Management sold 5,480 BioTelemetry, Inc. shares in Q4 2020, an estimated $250K.
  • AQR Capital Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 26 quarters.
  • AQR Capital Management's BioTelemetry, Inc. position peaked at $4.17M in Q3 2016.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.